Imeron

Iomeprol, the active ingredient in Imeron, is an iodinated contrast agent presented as an injection solution for intraarterial and intravenous use. It is marketed in the EU as a diagnostic radiographic contrast medium that increases X‑ray attenuation of blood and tissues, thereby improving visualization of vascular structures and organs during imaging studies.

GNH USA supplies Imeron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Imeron (iomeprol) is used in diagnostic imaging procedures that require vascular or organ contrast enhancement. - Angiography: provides enhanced visualization of blood vessels for accurate assessment. - Computed tomography (CT) imaging: improves delineation of anatomical structures and lesions. - Urography: highlights urinary tract anatomy for better diagnostic interpretation. - Contrast‑enhanced magnetic resonance imaging (MRI) (off‑label): offers supplementary contrast when required. - Other diagnostic imaging procedures requiring vascular or organ contrast: facilitates clearer imaging across various modalities.

Imeron may cause a range of adverse reactions following administration.

Common Side Effects: - Warmth or flushing sensation during injection. - Metallic taste or mild nausea. - Headache or mild dizziness. - Transient injection site discomfort. - Mild vomiting.

Serious or Rare Side Effects: - Severe allergic reactions, including anaphylaxis. - Acute kidney injury, especially in patients with pre‑existing renal impairment. - Hypotension or cardiovascular collapse. - Seizures or neurologic disturbances. - Life‑threatening pulmonary edema.

Prior to using Imeron, clinicians should consider several safety measures. - Assess renal function: evaluate serum creatinine and eGFR before administration. - Review allergy history: identify prior reactions to iodinated contrast agents. - Use the lowest effective dose: tailor volume to the specific imaging protocol. - Monitor vital signs: observe patients during and after injection for adverse events. - Avoid in patients with known severe iodine allergy: consider alternative imaging methods. - Store at ambient temperature: keep in original container, protect from light, and do not freeze.

Imeron may interact with other medications, requiring careful management.

Major Interactions (Avoid): - Concurrent use of multiple iodinated contrast agents: increases total iodine load and risk of toxicity. - Co‑administration with nephrotoxic drugs (e.g., aminoglycosides, NSAIDs): may exacerbate renal impairment. - Use with high‑dose beta‑blockers: can mask contrast‑induced hypertension.

Moderate Interactions (Monitor Closely): - Combination with diuretics: may affect fluid balance and renal clearance. - Metformin therapy in patients with reduced renal function: temporary discontinuation recommended. - Anticoagulants: monitor for bleeding if contrast‑induced renal dysfunction occurs.